Genmab
GMAB
#1312
Rank
โ‚น1.145 T
Marketcap
โ‚น1,732
Share price
1.10%
Change (1 day)
-32.94%
Change (1 year)

Revenue for Genmab (GMAB)

Revenue in 2024 (TTM): โ‚น241.97 Billion

According to Genmab's latest financial reports the company's current revenue (TTM ) is โ‚น247.30 Billion. In 2023 the company made a revenue of โ‚น198.44 Billion an increase over the revenue in the year 2022 that were of โ‚น170.04 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Genmab from 2009 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น241.97 B21.93%
2023 โ‚น198.44 B16.7%
2022 โ‚น170.04 B72.56%
2021 โ‚น98.54 B-13.85%
2020 โ‚น114.39 B99.75%
2019 โ‚น57.26 B72.46%
2018 โ‚น33.20 B40.39%
2017 โ‚น23.65 B31.33%
2016 โ‚น18.00 B61.56%
2015 โ‚น11.14 B18.61%
2014 โ‚น9.39 B28.23%
2013 โ‚น7.32 B58.01%
2012 โ‚น4.63 B35.23%
2011 โ‚น3.43 B-25.49%
2010 โ‚น4.60 B-9.15%
2009 โ‚น5.06 B